allergy therapies (Calyx)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameallergy therapies (Calyx)
Drug Alias NameCLX-2200ECLX-2300ECLX-2100E
ClassificationSmall molecules
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCalyx Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCalyx Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsHypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A